Hedge Fund - Opti Capital Management
Supernus Pharmaceuticals Inc. (SUPN) NOTE 0.625% 4/0
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q2 (2023-06-30) | $0 | 0% | 0 | $34.99 |
| 2 | 2023 - Q1 (2023-03-31) | $46,902,000 | 3.79% | 46,902,000 | $38.45 |
| 3 | 2022 - Q4 (2022-12-31) | $46,257,098 | 3.98% | 46,902,000 | $34.75 |
| 4 | 2022 - Q3 (2022-09-30) | $45,824,000 | 4.24% | 46,902,000 | $32.54 |
| 5 | 2022 - Q2 (2022-06-30) | $45,737,000 | 4.39% | 46,902,000 | $28.64 |
| 6 | 2022 - Q1 (2022-03-31) | $46,433,000 | 3.73% | 46,902,000 | $30.66 |
| 7 | 2021 - Q4 (2021-12-31) | $45,147,000 | 3.42% | 45,402,000 | $30.34 |
| 8 | 2021 - Q3 (2021-09-30) | $44,828,000 | 4.2% | 45,402,000 | $26.84 |
| 9 | 2021 - Q2 (2021-06-30) | $37,062,000 | 3.97% | 37,347,000 | $30.66 |
| 10 | 2021 - Q1 (2021-03-31) | $36,345,000 | 4.43% | 37,347,000 | $27.97 |
| 11 | 2020 - Q4 (2020-12-31) | $36,963,000 | 4.12% | 38,801,000 | $21.52 |
| 12 | 2020 - Q3 (2020-09-30) | $38,713,000 | 4.73% | 41,818,000 | $22.70 |
| 13 | 2020 - Q2 (2020-06-30) | $37,385,000 | 6.38% | 41,828 | $22.09 |
| 14 | 2020 - Q1 (2020-03-31) | $33,718,000 | 6.9% | 41,026 | $21.01 |
| 15 | 2019 - Q4 (2019-12-31) | $8,701,000 | 1.3% | 9,562 | $24.29 |
The displayed share prices are average quarterly stock market prices.